{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:17:44Z","timestamp":1793276264319,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01 DK130386"],"award-info":[{"award-number":["R01 DK130386"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1053\/j.akdh.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:05:36Z","timestamp":1722243936000},"page":"290-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Collapsing Glomerulopathy"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-0893","authenticated-orcid":false,"given":"Abbal","family":"Koirala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-7991","authenticated-orcid":false,"given":"Shreeram","family":"Akilesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ashley","family":"Jefferson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.akdh.2024.03.008_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM198403153101101","article-title":"Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome","volume":"310","author":"Rao","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1053\/j.akdh.2024.03.008_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D\u2019Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.008_bib3","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1053\/j.ajkd.2015.04.009","article-title":"AJKD Atlas of renal pathology: collapsing glomerulopathy","volume":"66","author":"Fogo","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.akdh.2024.03.008_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.V10151","article-title":"The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"10","author":"Barisoni","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.03.008_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1681\/ASN.2008070795","article-title":"Recruitment of podocytes from glomerular parietal epithelial cells","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.03.008_bib6","doi-asserted-by":"crossref","first-page":"F1375","DOI":"10.1152\/ajprenal.00020.2013","article-title":"Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS","volume":"304","author":"Zhang","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.akdh.2024.03.008_bib7","doi-asserted-by":"crossref","first-page":"F702","DOI":"10.1152\/ajprenal.00428.2009","article-title":"De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease","volume":"298","author":"Ohse","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.akdh.2024.03.008_bib8","doi-asserted-by":"crossref","first-page":"F571","DOI":"10.1152\/ajprenal.00516.2011","article-title":"De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy","volume":"302","author":"Zhang","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.akdh.2024.03.008_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.2014.92","article-title":"Histopathologic findings associated with APOL1 risk variants in chronic kidney disease","volume":"28","author":"Larsen","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1053\/j.akdh.2024.03.008_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ckj\/sfx029","article-title":"Collapsing glomerulopathy: a 30-year perspective and single, large center experience","volume":"10","author":"Cossey","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1053\/j.akdh.2024.03.008_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1523-1755.2004.00715.x","article-title":"Proteinuria in rats induced by serum from patients with collapsing glomerulopathy","volume":"66","author":"del Carmen Avila-Casado","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2024.03.008_bib12","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 Localization in normal kidney and Nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.03.008_bib13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1053\/j.akdh.2024.03.008_bib14","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMc1800748","article-title":"Worldwide Frequencies of APOL1 renal risk variants","volume":"379","author":"Nadkarni","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.akdh.2024.03.008_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1053\/j.akdh.2024.03.008_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1681\/ASN.2016040441","article-title":"Most ApoL1 is secreted by the liver","volume":"28","author":"Shukha","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.03.008_bib17","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1681\/ASN.2015101121","article-title":"Plasma levels of risk-variant APOL1 do not associate with renal disease in a population-based Cohort","volume":"27","author":"Kozlitina","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.03.008_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.semnephrol.2017.07.008","article-title":"APOL1 nephrotoxicity: what does ion transport have to do with it?","volume":"37","author":"Olabisi","year":"2017","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41581-022-00538-3","article-title":"The evolving story of apolipoprotein L1 nephropathy: the end of the beginning","volume":"18","author":"Daneshpajouhnejad","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib20","doi-asserted-by":"crossref","first-page":"e172262","DOI":"10.1172\/JCI172262","article-title":"APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease","volume":"134","author":"Datta","year":"2024","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1053\/j.akdh.2024.03.008_bib21","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1681\/ASN.2019020114","article-title":"APOL1 kidney risk variants induce cell death mitochondrial translocation and opening of the mitochondrial permeability transition pore","volume":"30","author":"Shah","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"10.1053\/j.akdh.2024.03.008_bib22","doi-asserted-by":"crossref","first-page":"e136329","DOI":"10.1172\/JCI136329","article-title":"The key role of NLRP3 and STING in APOL1-associated podocytopathy","volume":"131","author":"Wu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1053\/j.akdh.2024.03.008_bib23","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/febs.15133","article-title":"Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu","volume":"287","author":"Jha","year":"2020","journal-title":"FEBS J"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-\u03b1, -\u03b2, or -\u03b3 is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib25","first-page":"564","article-title":"Collapsing glomerulopathy after hepatitis C pegylated interferon treatment. Recovery of renal function with high-dose steroid treatment","volume":"3","author":"Berdichevski","year":"2010","journal-title":"NDT Plus"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.008_bib27","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1681\/ASN.V11112079","article-title":"Renal epithelium is a previously unrecognized site of HIV-1 infection","volume":"11","author":"Bruggeman","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2024.03.008_bib28","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1681\/ASN.V12122645","article-title":"Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy","volume":"12","author":"Ross","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.008_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41581-020-0332-3","article-title":"COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.008_bib30","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1681\/ASN.2021070931","article-title":"Longitudinal outcomes of COVID-19\u2013associated collapsing glomerulopathy and other Podocytopathies","volume":"32","author":"Kudose","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.008_bib31","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.008_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.2020060804","article-title":"COVID-19\u2013Associated glomerular disease","volume":"32","author":"Shetty","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.008_bib33","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-021-22781-1","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.008_bib34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2215\/CJN.04560421","article-title":"Evidence for and against direct kidney infection by SARS-CoV-2 in patients with COVID-19","volume":"16","author":"Hassler","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.008_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ajkd.2020.10.001","article-title":"Multicenter clinicopathologic correlation of kidney biopsies Performed in COVID-19 patients presenting with acute kidney injury or proteinuria","volume":"77","author":"Akilesh","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib36","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","article-title":"Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy","volume":"59","author":"Moudgil","year":"2001","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib37","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0272-6386(00)70055-2","article-title":"Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis","volume":"35","author":"Tanawattanacharoen","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.008_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ndt\/18.1.187","article-title":"Acute cytomegalovirus infection complicated by collapsing glomerulopathy","volume":"18","author":"Tomlinson","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ckj\/sfs059","article-title":"Acute Epstein\u2013Barr virus infection-associated collapsing glomerulopathy","volume":"5","author":"Joshi","year":"2012","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.008_bib40","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2215\/CJN.00590120","article-title":"Malaria, collapsing glomerulopathy, and focal and segmental glomerulosclerosis","volume":"15","author":"Amoura","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0971-4065.175981","article-title":"Collapsing glomerulopathy associated with pulmonary tuberculosis","volume":"26","author":"Srinivasaprasad","year":"2016","journal-title":"Indian J Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.008_bib42","first-page":"1353","article-title":"Collapsing focal segmental glomerulosclerosis associated with visceral leishmaniasis","volume":"9","author":"Leblond","year":"1994","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib43","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0272-6386(97)90090-1","article-title":"Secondary collapsing glomerulopathy associated with Loa loa filariasis","volume":"30","author":"Pakasa","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib44","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2215\/CJN.11751111","article-title":"Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease","volume":"7","author":"Salvatore","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.008_bib45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0961203310388446","article-title":"Collapsing glomerulopathy occurring in HIV-negative patients with systemic lupus erythematosus: report of three cases and brief review of the literature","volume":"20","author":"Gupta","year":"2011","journal-title":"Lupus"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.008_bib47","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.ki.5000352","article-title":"Nephrotic syndrome associated with hemophagocytic syndrome","volume":"69","author":"Thaunat","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib48","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1053\/j.ajkd.2003.11.025","article-title":"Collapsing glomerulopathy in adult still\u2019s disease","volume":"43","author":"Kumar","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.008_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0961203313513509","article-title":"Collapsing glomerulopathy in collagen vascular-like disease","volume":"23","author":"Nasr","year":"2014","journal-title":"Lupus"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ki.2010.521","article-title":"Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?","volume":"79","author":"Cook","year":"2011","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2010.460","article-title":"Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies","volume":"79","author":"Karoui","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.008_bib52","first-page":"233","article-title":"Multiple myeloma presenting as collapsing glomerulopathy","volume":"46","author":"Bhowmik","year":"2003","journal-title":"Indian J Pathol Microbiol"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib53","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1046\/j.1523-1755.1999.00769.x","article-title":"Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study","volume":"56","author":"Laurinavicius","year":"1999","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib54","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1053\/j.ajkd.2011.07.011","article-title":"Collapsing glomerulopathy associated with natural killer cell leukemia: a case report and review of the literature","volume":"58","author":"Palma Diaz","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib55","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41379-018-0154-z","article-title":"Collapsing glomerulopathy in older adults","volume":"32","author":"Kukull","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib56","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.kint.2016.07.021","article-title":"Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney","volume":"90","author":"Buob","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0272-6386(99)70216-7","article-title":"Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations","volume":"33","author":"Stokes","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib58","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.kint.2018.06.024","article-title":"Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts","volume":"94","author":"Santoriello","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.008_bib59","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.ki.5000234","article-title":"Sickle cell disease, nephrotic syndrome, and renal failure","volume":"69","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.008_bib60","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0272-6386(97)90193-1","article-title":"Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations","volume":"29","author":"Greenberg","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.008_bib61","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2009.07.014","article-title":"Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries","volume":"55","author":"Canaud","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.008_bib62","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ndt\/gft408","article-title":"Collapsing glomerulopathy superimposed on diabetic nephropathy: insights into etiology of an under-recognized, severe pattern of glomerular injury","volume":"29","author":"Salvatore","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.008_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/ijn.IJN_334_17","article-title":"Collapsing glomerulopathy superimposed on diabetic nephropathy","volume":"29","author":"Etta","year":"2019","journal-title":"Indian J Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2024.03.008_bib64","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"Markowitz","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.008_bib65","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1523-1755.2004.00426.x","article-title":"Podocyte injury associated glomerulopathies induced by pamidronate","volume":"65","author":"Barri","year":"2004","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.008_bib66","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.008_bib67","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00198-007-0361-9","article-title":"Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate","volume":"18","author":"Pascual","year":"2007","journal-title":"Osteoporosis International"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.008_bib68","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","article-title":"Bisphosphonate nephrotoxicity","volume":"74","author":"Perazella","year":"2008","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.008_bib69","first-page":"249","article-title":"Reversibility of pamidronate-associated glomerulosclerosis","volume":"20","author":"Shreedhara","year":"2007","journal-title":"SAVE Proc"},{"issue":"1","key":"10.1053\/j.akdh.2024.03.008_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1681\/ASN.2009040450","article-title":"Development of focal segmental glomerulosclerosis after anabolic steroid abuse","volume":"21","author":"Herlitz","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib71","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/hupa.2002.124333","article-title":"Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes","volume":"33","author":"Nadasdy","year":"2002","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1053\/j.akdh.2024.03.008_bib72","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00007890-199805150-00009","article-title":"De Novo collapsing glomerulopathy IN renal ALLOGRAFTS1","volume":"65","author":"Meehan","year":"1998","journal-title":"Transplantation"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.008_bib73","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1681\/ASN.2006080833","article-title":"COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement","volume":"18","author":"Diomedi-Camassei","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.008_bib74","doi-asserted-by":"crossref","first-page":"F1228","DOI":"10.1152\/ajprenal.00143.2013","article-title":"Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10","volume":"305","author":"Gasser","year":"2013","journal-title":"Am J Physiol Ren Physiol"},{"issue":"11","key":"10.1053\/j.akdh.2024.03.008_bib75","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1007\/s00467-020-04914-8","article-title":"Primary coenzyme Q10 nephropathy, a potentially treatable form of steroid-resistant nephrotic syndrome","volume":"36","author":"Tan","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib76","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5414\/CN106544","article-title":"Familial collapsing focal segmental glomerulosclerosis","volume":"75","author":"Liakopoulos","year":"2011","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib77","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1053\/j.ajkd.2008.01.018","article-title":"Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism","volume":"51","author":"Choi","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib78","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2353\/ajpath.2010.090746","article-title":"A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue","volume":"177","author":"Hodgin","year":"2010","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib79","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.kint.2022.01.033","article-title":"Digital spatial profiling of collapsing glomerulopathy","volume":"101","author":"Smith","year":"2022","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.008_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MNH.0000000000000873","article-title":"Collapsing glomerulopathy: unraveling varied pathogeneses","volume":"32","author":"Smith","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib81","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ki.1994.185","article-title":"Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis","volume":"45","author":"Detwiler","year":"1994","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2024.03.008_bib82","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0272-6386(99)70215-5","article-title":"Collapsing glomerulopathy: clinical characteristics and follow-up","volume":"33","author":"Grcevska","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"4S","key":"10.1053\/j.akdh.2024.03.008_bib83","first-page":"S1","article-title":"KDIGO 2021 clinical Practice Guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2024.03.008_bib84","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/ki.1996.493","article-title":"Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study","volume":"50","author":"Valeri","year":"1996","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.008_bib85","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.13091215","article-title":"Renal survival in patients with collapsing compared with not otherwise specified FSGS","volume":"11","author":"Laurin","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.008_bib86","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2215\/CJN.07110615","article-title":"Treatment with glucocorticoids or calcineurin inhibitors in primary FSGS","volume":"11","author":"Laurin","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2024.03.008_bib87","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.ki.5001903","article-title":"Cellular focal segmental glomerulosclerosis: clinical and pathologic features","volume":"70","author":"Stokes","year":"2006","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.008_bib88","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2024.03.008_bib89","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1582-4934.2011.01398.x","article-title":"Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney","volume":"16","author":"Descazeaud","year":"2012","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.008_bib90","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2215\/CJN.01920218","article-title":"Complications of immunosuppression in glomerular disease","volume":"13","author":"Jefferson","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.03.008_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126124","article-title":"Antisense oligonucleotide treatment ameliorates IFN-\u03b3-induced proteinuria in APOL1-transgenic mice","volume":"4","author":"Aghajan","year":"2019","journal-title":"JCI Insight"},{"issue":"26","key":"10.1053\/j.akdh.2024.03.008_bib94","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for proteinuric kidney disease in Persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.akdh.2024.03.008_bib95","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1053\/j.akdh.2024.03.008_bib96","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.clim.2013.04.008","article-title":"Inflammasome and cytokine blocking strategies in autoinflammatory disorders","volume":"147","author":"Moll","year":"2013","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1053\/j.akdh.2024.03.008_bib97","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/00007890-199804150-00027","article-title":"Recurrent collapsing glomerulopathy","volume":"65","author":"Toth","year":"1998","journal-title":"Transplantation"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T04:56:56Z","timestamp":1728536216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813924000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2949813924000582"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.03.008","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collapsing Glomerulopathy","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}